Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

L.A. McKeown

December 22, 2022

News Conference News AHA 2022

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Michael O'Riordan

November 10, 2022

News Daily News

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Caitlin E. Cox

January 25, 2022

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Todd Neale

November 14, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News AHA 2017

More Support for TMVR After Failed Mitral Bioprostheses

Yael L. Maxwell

November 23, 2017

News Daily News

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Michael O'Riordan

May 04, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

L.A. McKeown

November 08, 2015

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

Advertisement

November 2024 Dispatch for the CV Team

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly

Partial Oral Antibiotic Regimen for Endocarditis Effective in Real World

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Roughly 80% of ESC Guideline Writers Have Financial COIs

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

TCTMD’s Top 10 Most Popular Stories for August 2020

Top News in Clinical Cardiology: 2018

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

More Support for TMVR After Failed Mitral Bioprostheses

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content